$11.260
-1.370 (-12.17%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NVAX por análisis de gráficos similares
Alphio's NVAX stock price prediction model matches the current Novavax Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.33 (+0.61%). The 1-week path is $11.19 (-0.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Novavax Inc?
Novavax Inc is currently not a strong buy due to its recent price decline and mixed financial performance. The current price is $11.26, and the stock has experienced a 5-day change of -11.69%. Additionally, the RSI is at 39.319, indicating that the stock is nearing oversold territory but has not yet reversed its downward trend. The forward P/E ratio is 2.58, suggesting potential undervaluation, but the analyst price targets range from $8 to $9, indicating limited upside from current levels. The main risk is the recent negative sentiment, as the stock has dropped 10% following news of a broader market pullback in biotech stocks, which could further impact investor confidence.
NVAX cerró en $11.26 el Friday, tras bajar -12.17%
Novavax Inc (NVAX) last closed at $11.26, losing -12.17%. These facts feed the 1-day and 1-week NVAX price prediction above.
Consenso de analistas
Novavax Inc (NVAX): 2 comprar, 5 mantener, 0 vender. Perspectiva: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Novavax Inc (NVAX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NVAX, ordenadas por similitud.
Análisis de estacionalidad de NVAX
Historically the probability of a positive October return for NVAX is 82.76%. October offers the highest probability of a positive month at 82.76%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NVAX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $6.81 | $14.48 | $20.23 | +28.59% |
| Nov 2026 | $13.30 | $16.55 | $24.49 | +47.02% |
| Dec 2026 | $4.06 | $10.95 | $12.67 | -2.72% |
En 2026, se proyecta que Novavax Inc (NVAX) oscile entre $4.06 y $24.49.
Previsión mensual de Novavax Inc para 2026
En Oct de 2026, se proyecta que Novavax Inc promedie $14.48, con un mínimo de $6.81 y un máximo de $20.23.
En Nov de 2026, se proyecta que Novavax Inc promedie $16.55, con un mínimo de $13.30 y un máximo de $24.49.
En Dec de 2026, se proyecta que Novavax Inc promedie $10.95, con un mínimo de $4.06 y un máximo de $12.67.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.